Pharma Strikes Out At Supreme Court As Three Recent Cert Petitions Fail
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer, Cephalon and former InterMune CEO Scott Harkonen will find no relief from the high court.
You may also be interested in...
Regeneron's Patent Pratfall: First Inequitable Conduct, Now Possible Sanctions
After losing patent infringement suit against Merus involving antibody-producing mouse, Regeneron fights ruling that it withheld material information in prosecuting the patent.
Appeals Court Revives RICO Off-Label Suit Against Abbott
Seventh Circuit reinstates employer benefit funds’ complaint over off-label promotion of Depakote, allowing them to make case they were not properly compensated; courts have issued disparate opinions in such cases.
Off-Label Is Off The Docket: Supreme Court Leaves RU-486 Flexibility Intact
High court declines to intervene in dispute over Arizona law that would restrict use of abortion drug; court also denies Roche petition for review of Boniva patent ruling.